HL Financial Services LLC Has $588,000 Holdings in Danaher Corporation (DHR)
HL Financial Services LLC lowered its position in shares of Danaher Corporation (NYSE:DHR) by 12.6% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 6,857 shares of the conglomerate’s stock after selling 990 shares during the quarter. HL Financial Services LLC’s holdings in Danaher Corporation were worth $588,000 as of its most recent filing with the SEC.
A number of other institutional investors have also recently made changes to their positions in the business. Courier Capital LLC purchased a new position in Danaher Corporation during the 3rd quarter worth $224,000. FDx Advisors Inc. raised its position in Danaher Corporation by 6.1% during the 3rd quarter. FDx Advisors Inc. now owns 36,768 shares of the conglomerate’s stock worth $3,154,000 after buying an additional 2,127 shares during the last quarter. Global X MANAGEMENT CO LLC raised its position in Danaher Corporation by 20.7% during the 3rd quarter. Global X MANAGEMENT CO LLC now owns 4,354 shares of the conglomerate’s stock worth $373,000 after buying an additional 746 shares during the last quarter. Candriam Luxembourg S.C.A. raised its position in Danaher Corporation by 97.4% during the 3rd quarter. Candriam Luxembourg S.C.A. now owns 119,220 shares of the conglomerate’s stock worth $10,227,000 after buying an additional 58,823 shares during the last quarter. Finally, Spectrum Asset Management Inc. NB CA raised its position in Danaher Corporation by 5.8% during the 3rd quarter. Spectrum Asset Management Inc. NB CA now owns 11,275 shares of the conglomerate’s stock worth $967,000 after buying an additional 620 shares during the last quarter. Institutional investors own 75.56% of the company’s stock.
A number of equities analysts have recently issued reports on the stock. Robert W. Baird increased their price target on shares of Danaher Corporation from $87.00 to $97.00 and gave the company an “outperform” rating in a report on Friday, October 20th. Credit Suisse Group increased their price target on shares of Danaher Corporation from $93.00 to $96.00 and gave the company an “outperform” rating in a report on Friday, October 20th. Morgan Stanley increased their price target on shares of Danaher Corporation from $95.00 to $98.00 and gave the company an “overweight” rating in a report on Friday, October 20th. Zacks Investment Research upgraded shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 price target for the company in a report on Thursday, October 5th. Finally, J P Morgan Chase & Co reiterated an “overweight” rating and issued a $95.00 price target on shares of Danaher Corporation in a report on Friday, September 8th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Danaher Corporation presently has an average rating of “Buy” and a consensus price target of $93.31.
ILLEGAL ACTIVITY NOTICE: This report was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this report on another site, it was copied illegally and reposted in violation of international trademark and copyright law. The correct version of this report can be read at https://www.watchlistnews.com/hl-financial-services-llc-has-588000-holdings-in-danaher-corporation-dhr/1721603.html.
Shares of Danaher Corporation (NYSE DHR) opened at $93.76 on Thursday. The company has a market cap of $65,512.09, a PE ratio of 24.21, a P/E/G ratio of 2.24 and a beta of 1.02. Danaher Corporation has a 12 month low of $76.27 and a 12 month high of $94.24. The company has a quick ratio of 1.00, a current ratio of 1.43 and a debt-to-equity ratio of 0.42.
Danaher Corporation (NYSE:DHR) last released its quarterly earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.95 by $0.05. Danaher Corporation had a net margin of 13.36% and a return on equity of 11.29%. The company had revenue of $4.53 billion for the quarter, compared to analysts’ expectations of $4.47 billion. During the same period last year, the company earned $0.87 EPS. The firm’s revenue for the quarter was up 9.6% compared to the same quarter last year. equities analysts anticipate that Danaher Corporation will post 3.99 earnings per share for the current year.
The company also recently declared a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Friday, September 29th were paid a dividend of $0.14 per share. The ex-dividend date of this dividend was Thursday, September 28th. This represents a $0.56 annualized dividend and a dividend yield of 0.60%. Danaher Corporation’s dividend payout ratio is currently 16.52%.
In other Danaher Corporation news, CFO Daniel L. Comas sold 88,184 shares of the firm’s stock in a transaction dated Monday, October 23rd. The shares were sold at an average price of $91.02, for a total transaction of $8,026,507.68. Following the sale, the chief financial officer now directly owns 227,816 shares of the company’s stock, valued at approximately $20,735,812.32. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider William King sold 43,688 shares of the firm’s stock in a transaction dated Thursday, August 31st. The stock was sold at an average price of $82.86, for a total transaction of $3,619,987.68. Following the sale, the insider now directly owns 45,748 shares in the company, valued at $3,790,679.28. The disclosure for this sale can be found here. Insiders have sold a total of 317,498 shares of company stock worth $28,838,801 over the last ninety days. 12.20% of the stock is owned by corporate insiders.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.